Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series
Clinical trial NCT05457946 · UNKNOWN
Trial details
- NCT number
- NCT05457946
- Sponsor
- LG Chem
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-01
- Primary completion
- 2025-09-30
- Enrollment
- 1438
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.